Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia.
Vogel
F
F
Medizinische Klinik III, Krankenhaus Hofheim, Hofheim, Germany.
Ochs
H R
HR
Wettich
K
K
Kalich
S
S
Nilsson-Ehle
I
I
Odenholt
I
I
Nord
C E
CE
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use*; D002511:Cephalosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005243:Feces / Q000382:microbiology; D005260:Female; D006760:Hospitalization; D006801:Humans; D007262:Infusions, Intravenous; D007422:Intestines / Q000382:microbiology*; D008297:Male; D008875:Middle Aged; D011014:Pneumonia / Q000188:drug therapy*; D016896:Treatment Outcome
D002511:Cephalosporins; C054920:loracarbef; D002443:Ceftriaxone